Incontinence, Urge Clinical Trials

9 recruitingLast updated: May 13, 2026

There are 9 actively recruiting incontinence, urge clinical trials across 6 countries. Studies span Not Applicable, Phase 4. Top locations include Herlev, Denmark, Odense, Denmark, Aarhus, Denmark. Updated daily from ClinicalTrials.gov.


Incontinence, Urge Trials at a Glance

9 actively recruiting trials for incontinence, urge are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Herlev, Odense, and Aarhus. Lead sponsors running incontinence, urge studies include InnoCon Medical, Laborie Medical Technologies Inc., and Children's Hospital of Chongqing Medical University.

Browse incontinence, urge trials by phase

Treatments under study

About Incontinence, Urge Clinical Trials

Looking for clinical trials for Incontinence, Urge? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Incontinence, Urge trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Incontinence, Urge clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet

Overactive BladderUrinary Bladder, OveractiveUrinary Incontinence, Urge
Children's Hospital of Chongqing Medical University180 enrolled1 locationNCT06201013
Recruiting
Not Applicable

Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assessed by PROMs.

Sexual FunctionWomen's healthQuality of Life+7 more
Mucosa Innovations, S.L.80 enrolled1 locationNCT06962345
Recruiting
Phase 4

TReating Incontinence for Underlying Mental and Physical Health

IncontinenceUrinary IncontinenceOveractive Bladder+3 more
University of California, San Francisco270 enrolled2 locationsNCT05362292
Recruiting
Not Applicable

Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfunction (BD)

NocturiaUrinary IncontinenceFecal Incontinence+5 more
InnoCon Medical20 enrolled3 locationsNCT06091566
Recruiting
Not Applicable

UCon Treatment of Overactive Bladder (OAB) in Males

NocturiaUrge incontinenceUrinary Incontinence+3 more
InnoCon Medical20 enrolled1 locationNCT05874375
Recruiting

Implementation of the App Tät®II for Treatment of Urgency and Mixed Urinary Incontinence

Urgency IncontinenceMixed Incontinence, Urge and Stress
Umeå University60 enrolled1 locationNCT07038811
Recruiting
Not Applicable

Safety and Performance of UCon Patch Electrode

NocturiaUrinary IncontinenceFecal Incontinence+5 more
InnoCon Medical180 enrolled3 locationsNCT06754189
Recruiting

NXT Post-Market Clinical Follow-up

Urinary IncontinenceUrinary Bladder, NeurogenicUrinary Bladder, Overactive+2 more
Laborie Medical Technologies Inc.180 enrolled4 locationsNCT06336304
Recruiting
Phase 4

Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A

NocturiaUrinary Urge IncontinenceIncontinence, Urinary+3 more
University of South Florida60 enrolled2 locationsNCT04305743